Catalysis is an essential component in modern pharmaceutical manufacturing, enabling the efficient production of complex drugs and advancing the development of new therapeutic agents. Catalysis in medicine and pharmaceuticals is used to accelerate chemical reactions, enhancing reaction rates and selectivity while minimizing the need for harsh reaction conditions, toxic solvents, and excessive by-products. This is particularly important for the synthesis of high-value, low-volume drugs, where maximizing yield and minimizing waste are key considerations. Catalysis also plays a critical role in the synthesis of chiral compounds, which are crucial for creating effective pharmaceuticals with the desired biological activity. Asymmetric catalysis, which enables the selective formation of one stereoisomer over another, has revolutionized the production of chiral drugs and is now routinely used in the synthesis of many widely prescribed medications. In addition to small-molecule drugs, catalysis is also being applied to the development of biologics, such as therapeutic proteins and gene therapies. Enzyme-based catalysis, for example, can help with the efficient modification and production of monoclonal antibodies and other biologic therapeutics. Catalysts are also used in the synthesis of prodrugs, which are inactive compounds that are converted into their active form once administered to the body, offering improved drug delivery profiles and reduced side effects. The integration of catalysis into pharmaceutical manufacturing processes not only improves the efficiency of drug production but also enables the development of more sustainable and environmentally friendly processes, which are critical in meeting the growing demand for healthcare solutions.
Submit your abstract Today
